Home » GlaxoSmithKline Adds to its Commitment to GAVI Alliance
GlaxoSmithKline Adds to its Commitment to GAVI Alliance
GlaxoSmithKline has agreed to provide an extra 240 million doses of Synflorix, a vaccine that protects against diseases such as pneumonia and meningitis, to developing countries over the next 10 years.
WorldPharmaNews
WorldPharmaNews
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May